本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rocket Pharmaceuticals, Inc.

3.48
+0.07002.05%
盤前3.490.0100+0.29%04:11 EDT
成交量:264.47萬
成交額:921.39萬
市值:3.82億
市盈率:-20.47
高:3.57
開:3.57
低:3.40
收:3.41
52周最高:5.45
52周最低:2.53
股本:1.10億
流通股本:8,539.15萬
量比:1.53
換手率:3.10%
股息:- -
股息率:- -
每股收益(TTM):-0.1700
每股收益(LYR):-2.0100
淨資產收益率:-4.77%
總資產收益率:-28.42%
市淨率:1.04
市盈率(LYR):-1.73

資料載入中...

2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/08

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/13

重要事件披露

Form 8-K - Current report
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities